As indicated by in vitro studies, both lipogenesis and lipolysis in adipocytes depend on the cellular ATP levels. Ectopic expression of mitochondrial uncoupling protein 1 (UCP1) in the white adipose tissue of the aP2-Ucp1 transgenic mice reduced obesity induced by genetic or dietary manipulations. Furthermore, respiratory uncoupling lowered the cellular energy charge in adipocytes, while the synthesis of fatty acids (FA) was inhibited and their oxidation increased. Importantly, the complex metabolic changes triggered by ectopic UCP1 were associated with the activation of AMP-activated protein kinase (AMPK), a metabolic master switch, in adipocytes. Effects of several typical treatments that reduce adiposity, such as administration of leptin, b-adrenoceptor agonists, bezafibrate, dietary n-3 polyunsaturated FA or fasting, can be compared with a phenotype of the aP2-Ucp1 mice. These situations generally lead to the upregulation of mitochondrial UCPs and suppression of the cellular energy charge and FA synthesis in adipocytes. On the other hand, FA oxidation is increased. Moreover, it has been shown that AMPK in adipocytes can be activated by adipocyte-derived hormones leptin and adiponectin, and also by insulin-sensitizes thiazolidinediones. Thus, it is evident that metabolism of adipose tissue itself is important for the control of body fat content and that the cellular energy charge and AMPK are involved in the control of lipid metabolism in adipocytes. The reciprocal link between synthesis and oxidation of FA in adipocytes represents a prospective target for the new treatment strategies aimed at reducing obesity.
Introduction
Obesity, an excessive accumulation of adipose tissue, leads to various metabolic complications including cardiovascular disease, hypertension, dyslipidemia, and type II diabetes, together designated as metabolic syndrome. The prevalence of obesity has increased in industrialized countries and the economic costs of obesity range from 2 to 7% of their total health-care budget. 1 In order to preserve energy stored as triacylglycerols (TG) in adipose tissue, a number of regulatory mechanisms have developed in order to help the body maintain stable levels of energy stores. [2] [3] [4] Such mechanisms involve the central control of behavior and thermogenesis mediated by neuroendocrine system, control of metabolite fluxes among various organs, and, finally, energy metabolism within individual tissues. Due to the complex nature of this process, any treatment strategy for obesity is difficult. Many pieces of evidence suggest that body fat content is controlled, at least partially, by the metabolism of adipose tissue itself. First, many candidate genes for obesity have important roles in adipocytes. 5 Second, mice that are prone or resistant to obesity were created by transgenic modification of adipose tissue (for a review, see Kopecky et al 6 ). In these transgenic models, metabolic changes in white adipose tissue are mostly responsible for the altered accretion of body fat and associated metabolic disorders. The characteristic feature associated with obesity and the pivotal factor in the pathogenesis of type II diabetes is insulin resistance. 7, 8 Reduced ability of peripheral tissues, particularly skeletal muscle and liver, to respond to insulin stimulation can be detected many years before the clinical onset of hyperglycemia. In obese subjects, insulin resistance most likely results from an increased accumulation of lipids in peripheral tissues due to enhanced release of fatty acids (FA) from hypertrophic fat cells. 9 In fact, hypertrophic adipocytes themselves become resistant to insulin, which results in a lower clearance of plasma TG and higher FA release from adipose tissue. It was observed that insulin resistance also develops as the consequence of a lack of white adipose tissue. 10, 11 Under these circumstances, levels of circulating FA are elevated due to insufficient 'buffering' capacity of adipocytes for FA. Consequently, excess lipids are deposited in other organs and insulin resistance develops. [12] [13] [14] In addition to FA, also various adipocyte-secreted proteins ('adipokines') like leptin, adiponectin, tumor necrosis factor a, interleukin-6, and resistin modulate sensitivity of other tissues to insulin and may be involved in the induction of systemic insulin resistance. 15, 16 Thus, adipose tissue metabolism together with adipokines are involved in the control of systemic insulin sensitivity. Only a few laboratories have focused their research efforts on the link between energy and lipid metabolism in white adipose tissue. In vitro studies demonstrate that a decrease in mitochondrial ATP production resulted in the inhibition of both FA synthesis 17 and lipolytic action of catecholamines, 18 and in the enhancement of glycolysis due to respiratory uncoupling in adipocytes. 17 Without complementary in vivo studies, the significance of these findings would be limited. We contributed to this topic through our studies on the mechanism, by which ectopic expression of mitochondrial uncoupling protein 1 (UCP1) in white fat of the aP2-Ucp1 transgenic mice protects against obesity. These studies clarified several aspects involved in the modulation of lipid metabolism in adipose tissue by cellular energy charge, as well as the role of AMP-activated protein kinase (AMPK) in this process.
Reduced adiposity due to respiratory uncoupling in white fat of the aP2-Ucp1 transgenic mice
Transgenic aP2-Ucp1 mice, in which the UCP1 gene is driven by the fat-specific aP2 promoter to achieve enhanced expression in both brown and white fat, represent an excellent model to study the effects of respiratory uncoupling on fat accumulation in vivo. 19 These animals are partially resistant to obesity induced by age, genetic background, 19 and high-fat diet. 20, 21 Their resistance to obesity reflects lower accumulation of TG in all fat depots except for gonadal fat, which becomes relatively large. 19, 20 Importantly, obesity resistance results exclusively from a transgenic modification of white fat, 6 since brown fat in these mice is greatly atrophied. 22 Ectopic expression of transgenic UCP1 in white fat and its consequences have been studied in great detail. All unilocular adipocytes contained transgenic UCP1; however, the level of transgene expression differed in various fat depots with gonadal fat showing relatively low expression. 19, 23 This may partially explain why the effect of transgene on lipid accumulation was less pronounced in gonadal fat (see above). Nevertheless, even in this fat depot transgenic UCP1 was capable of decreasing mitochondrial membrane potential in adipocytes 24 and elevating oxygen consumption two-fold. 21 Importantly, mitochondrial biogenesis in unilocular adipocytes of transgenic mice was induced, probably due to upregulation of the transcription factor nuclear respiratory factor (NRF-1). 23 Since the total content of transgenic UCP1 in white fat of adult mice did not exceed 2% of UCP1 levels found in the interscapular brown fat of control mice, 19 it is clear that only minute amounts of ectopic UCP1 in unilocular adipocytes of white fat were sufficient to uncouple oxidative phosphorylation 24 and reduce accumulation of body fat.
In agreement with a low oxidative capacity of white fat, the increase in tissue oxygen consumption brought about by transgenic UCP1 (see above) resulted in only a marginal stimulation of resting metabolic rate in transgenic mice. 22 This suggests that, in addition to increased energy expenditure, there must be another way how transgenic UCP1 reduces adiposity. Indeed, a strong diminution of FA synthesis was found in greatly reduced subcutaneous fat depots of transgenic mice, while changes in gonadal fat were less obvious. 26 This probably reflects the magnitude of UCP1 expression 19, 23 as well as changes in the ATP/ADP ratio. The latter was observed only in the subcutaneous but not gonadal fat depot of transgenic mice. 25 Moreover, decreased FA synthesis was accompanied by a downregulation of acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), 26 and peroxisome proliferator-activated receptor g (PPARg) 27 in the white fat. Transgenic UCP1 lowered FA synthesis by means of respiratory uncoupling, as confirmed by experiments in vitro. 17, 26 Lipolysis and the activity of adipose tissue lipoprotein lipase (LPL) were also affected by the ectopic expression of UCP1 in white fat. For instance, the maximum lipolytic effect of noradrenaline was suppressed by 50% in subcutaneous but not gonadal fat of transgenic animals. In parallel, UCP1 transgene caused a downregulation of hormone-sensitive lipase (HSL), lowered its activity, and altered the expression of G-proteins in adipocytes. 25 The LPL activity in gonadal fat was higher in the transgenic compared to control mice, especially when the animals were fed a high-fat diet. 21 In agreement, we found that plasma TG levels were significantly lower in transgenic mice. 20 These data suggest that respiratory uncoupling in adipose tissue stimulates LPL-mediated clearance of TG. Phenotype of the aP2-Ucp1 transgenic mice indicates that the main physiological function of UCPs and respiratory uncoupling in white adipose tissue could be modulation of lipogenesis, oxidation of substrates, lipolysis, and hormonal control of lipid metabolism.
AMP-activated protein kinase
The broad range of metabolic effects triggered by ectopic UCP1 in the white adipose tissue of the aP2-Ucp1 transgenic mice (see above) is stunning and makes one search for a common governing mechanism. In the white fat, similar to other tissues, lipid and carbohydrate metabolism is modulated by AMPK, which serves as a metabolic master switch. In response to a fall in the cellular ATP/AMP ratio, AMPK becomes activated through phosphorylation of its a-subunit by an upstream kinase. Activated AMPK then phosphorylates and inactivates a number of enzymes involved in biosynthetic pathways, thus preventing further ATP utilization (for a review, see Winder and Hardie 28 ). In the skeletal muscle, AMPK also upregulates NRF-1, which induces mitochondrial biogenesis. 29 In the liver, the inhibitory effect of AMPK on lipogenesis is indirect, being mediated by suppression of the transcription factor sterol regulatory element binding protein (SREBP-1), 30 which upregulates genes engaged in lipogenesis. 31 In adipocytes, AMPK is known to inhibit both lipolysis and lipogenesis by regulating directly the enzymes engaged in lipid metabolism, 32 as well as by downregulating PPARg expression. 33 All the effects of transgenic UCP1 on the biochemical properties of white fat in the aP2-Ucp1 mice seem to be in agreement with the activation of AMPK (see above). Indeed, it was observed that UCP1-induced decrease in the ATP/ADP ratio in the subcutaneous white fat of transgenic mice 25 was also associated with a reduced ATP/ AMP ratio, increased activity of AMPK, and enhanced oxidation of FA. 27 Less dramatic changes were also observed in the gonadal fat of these mice. 27 Thus, activation of AMPK by decreased intracellular energy charge in the white fat of aP2-Ucp1 mice explains the complexity of changes in adipose tissue metabolism observed in this obesity-resistant transgenic model (Figure 1 ).
Role of UCPs in white adipose tissue
Similar to other cell types, mitochondria represent the main source of ATP in white adipocytes. Efficiency of ATP synthesis during oxidative phosphorylation depends on a proton leak through the inner mitochondrial membrane. Experiments of Brand et al 34 described basal proton leak in mitochondria as a general phenomenon. Several candidate genes encoding for proteins that could enable the regulated proton leak are expressed in adipocytes, namely the genes for various UCPs. In the brown fat, UCP1, UCP2, UCP3, and UCP5 genes are expressed, while in the white fat only UCP2 and UCP5 genes are normally active. 35, 36 Similar to UCP1, UCP2 and UCP3 might also enhance proton leak, induce respiratory uncoupling, and decrease ATP synthesis. 36, 37 It may be hypothesized that respiratory uncoupling in the white fat would increase energy expenditure and thermogenesis. However, the effect on energy balance may be relatively small, since white fat contributes to the resting metabolic rate in humans by only about 5%. 38 On the other hand, a decrease in ATP synthesis due to respiratory uncoupling in white fat with a consequent rise in ADP and AMP levels may result in allosteric regulations of key enzymes of carbohydrate and lipid metabolism. Based on its function during adaptive thermogenesis in adipocytes of the brown fat, UCP1 is the only homologue with a proven uncoupling activity. 39 Brown fat is present in all mammalian neonates, but in large nonhibernating species its content is greatly reduced. However, some brown adipocytes interspersed in white fat depots could be detected even in humans, 40 especially in perirenal depot, 41 and adult humans retain some capacity to induce brown adipocytes, as shown in patients with pheochromocytoma. 42 In abdominal fat, UCP1 mRNA levels are inversely related to the level of obesity, 43 similarly to UCP2. 44 Research efforts in many laboratories have focused on the biology of UCP1 expression in white adipose tissue as the possible means of reducing adiposity. For instance, treatments with b3-adrenergic agonists or exposure of animals to a cold stress upregulated the UCP1 expression, induced brown adipocytes in white fat, and reduced adiposity in mice 45, 46 and rats. 47 In rats, brown adipocyte-like cells induced in white fat seem to have two origins; that is, most come from convertible unilocular white adipocytes and express UCP3, while the rest (B8%) comes from precursor cells and expresses UCP1. 48 The induction of UCP1 in white fat depots, at least in mice, appears to be a highly variable genetic trait 46 and first analyses of this quantitative trait are underway. 49, 50 Importantly, human adipocytes in culture can be stimulated to express UCP1 gene following the exposure to adrenergic agonists 51 or thiazolidinediones (TZD). 52 Adenovirus-mediated transfer of human PPARg coactivator 1a (PGC-1a) into human subcutaneous white adipocytes induced the expression of UCP1, respiratory chain proteins, FA oxidation enzymes, and stimulated palmitate oxidation rate. 53 The signaling pathways that would orchestrate the induction of UCP1 and conversion of white adipocytes to fat-oxidizing brown fat-like cells in vivo 
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Expression PPAR expression Figure 1 The key role of AMPK in metabolic effects of respiratory uncoupling in the white fat of aP2-Ucp1 transgenic mice. Ectopically expressed UCP1 leads to a fall in the cellular ATP/AMP ratio and stimulation of AMPK. In turn, AMPK phosphorylates and inactivates a number of enzymes involved in lipid metabolism, including HSL, ACC, and FAS. It also downregulates the expression of lipogenic genes, possibly through the effect on SREBP-1 and PPARg expression. This results in the inhibition of lipolysis and lipogenesis, while FA oxidation is increased probably due to low malonyl-CoA levels. AMPK also upregulates transcription factor NRF-1, which stimulates mitochondrial biogenesis. Full arrows indicate the changes detected in the aP2-Ucp1 mice. See text for details.
Energy charge and AMP-activated protein kinase M Rossmeisl et al are largely unknown, but a number of transcription factors and coactivators including PGC-1a 54, 55 and PPARd 56 are certainly involved. Interestingly, a negative correlation between heat production in adipocytes and body fat content has also been found. 38 All these results suggest that white adipocytes are capable of acquiring the features of brown adipocytes and could be directed toward a transcriptional program linked to energy dissipation and in situ fat oxidation.
Physiological relevance of energy metabolism and AMPK in white adipocytes
It is necessary to assess whether changes in energy metabolism occur in adipocytes during treatments that affect adiposity, insulin resistance, and other components of the metabolic syndrome. In this respect, the effects of several typical treatments such as administration of leptin, [57] [58] [59] [60] [61] bezafibrate, 62, 63 adrenoreceptor agonists, 48, [64] [65] [66] [67] [68] dietary n-3 polyunsaturated FA [69] [70] [71] or fasting 66, [72] [73] [74] can be compared with a phenotype of the aP2-Ucp1 transgenic mice. 20, 21, 26 In all of these situations, fat accumulation is reduced and disturbances related to the metabolic syndrome are improved. Importantly, in most cases the expression of various UCPs is upregulated, FA oxidation increased, in situ lipogenesis suppressed, and LPL-mediated clearance of TG in the white fat is augmented. Opposite changes in the activity of FA oxidation and lipogenesis probably reflect the elimination of an inhibitory effect of malonyl-CoA on the transport of FA into mitochondrial matrix mediated by carnitine palmitoyl transferase-1 (CPT-1). 75 In the white fat, due to a low activity of CPT-1, FA oxidation is relatively slow and FAs are directed towards esterification, 76 unless the oxidation is activated by leptin 77 and probably also by other treatments (see above). Alterations in the energy charge of adipocytes, as revealed by changes in the cellular ATP content and/or ATP/ ADP and ATP/AMP ratios, were detected not only in the aP2-Ucp1 mice, 25, 27 but also during fasting 66 and after administration of b-adrenergic agonists. 64, 66 Experiments in the aP2-Ucp1 transgenic mice strongly support a role of adipocyte AMPK in situations that lead to a reduction of adiposity. Adenovirus-induced hyperleptinemia in rats activates AMPK and induces mitochondrial biogenesis and transcription factors PGC-1a and FOXC2. 61 Figure 2 ). Future studies should elucidate how adipocytes respond to the above-mentioned treatments with respect to changes in their cellular energy charge and malonyl-CoA levels, and the mechanisms of their metabolic adaptations. New drugs developed to increase AMPK activity in the muscle and liver may also reduce body fat stores by activating AMPK in adipose tissue. Energy charge and AMP-activated protein kinase M Rossmeisl et al
